Abstract

The role of hybrid imaging with 2-[18F] flourodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT) is continuously evolving and now considered standard practice in evaluation of disease stage, treatment response, recurrent disease and follow-up for numerous primary malignancies. In gynecological malignancies FDG PET/CT plays an important role, not only in the assessment of disease in the pre-and post-therapy setting, but also in radiation therapy (RT) planning by defining the metabolically active gross tumor volume (GTV. The glucose analogue radiotracer, FDG, is by far the most utilized radiotracer in PET/CT and is typically seen with high uptake in malignant cells. The radiotracer FDG has a high sensitivity but low specificity for malignancy, as benign processes with an inflammatory response for example infection, are also FDG-avid. In the evaluation of the female pelvic region an awareness of potential confounding factors in the interpretation of FDG is essential as variations of FDG uptake occur in accordance with the menstrual cycle and the menopausal state. Incidental imaging findings in the female genital can pose differential diagnostic challenges as false-positive and false-negative findings in benign and malignant processes are not uncommon. Gynecological malignancies continue to pose major public health problems with cervical cancer as the fourth most common cancer in women ranking after breast cancer, colorectal cancer and lung cancer. Familiarity with frequently encountered benign and malignant variants and pitfalls in FDG PET/CT in the female pelvic region can aid the reader in differential diagnostic considerations.

Original languageEnglish
JournalSeminars in Nuclear Medicine
Volume51
Issue number6
Pages (from-to)593-610
Number of pages18
ISSN0001-2998
DOIs
Publication statusPublished - Nov 2021

Keywords

  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Lung Neoplasms
  • Positron Emission Tomography Computed Tomography
  • Positron-Emission Tomography

Fingerprint

Dive into the research topics of 'PET/CT Variants and Pitfalls in Gynecological Cancers'. Together they form a unique fingerprint.

Cite this